Journal of Histochemistry and Cytochemistry, Vol. 49, 79-86, January 2001, Copyright © 2001, The Histochemical Society, Inc.


ARTICLE

Time Course of Osteopontin, Osteocalcin, and Osteonectin Accumulation and Calcification After Acute Vessel Wall Injury

Alain-Pierre Gadeaua, Hervé Chauleta, Danièle Dareta, Mark Kockxb, Jean-Marie Daniel-Lamazièrea, and Claude Desgrangesa
a INSERM U441, Bordeaux, France
b Department of Pathology, A. Z. Middelheim, Antwerp, Belgium

Correspondence to: Alain-Pierre Gadeau, INSERM U441, Av du Haut Lévêque, 33600 Pessac, France. E-mail: alain.gadeau@bordeaux.inserm.fr


  Summary
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Although mineral deposits have long been described to be a prominent feature of atherosclerosis, the mechanisms of arterial calcification are not well understood. However, accumulation of the non-collagenous matrix bone-associated proteins, osteopontin, osteocalcin, and osteonectin, has been demonstrated in atheromatous plaques. The aim of this study was to evaluate the role of these proteins in arterial calcification and, more precisely, during the initiation of this process. A model of rapid aortic calcification was developed in rabbits by an oversized balloon angioplasty. Calcification was followed using von Kossa staining and osteopontin, osteocalcin, and osteonectin were identified using immunohistochemistry. The aortic injury was rapidly followed by calcified deposits that appeared in the media as soon as 2 days after injury and then accumulated in zipper-like structures. Osteonectin was not detected in calcified deposits at any time after injury. In contrast, osteopontin and osteocalcin were detected in 8- and 14-day calcified structures, respectively, but not in the very early 2-day mineral deposits. These results suggest that these matrix proteins, osteopontin, osteocalcin, and osteonectin, are not involved in the initiation step of the aortic calcification process and that the former two might play a role in the regulation of arterial calcification. (J Histochem Cytochem 49:79–86, 2001)

Key Words: atherosclerosis, calcifications, extracellular matrix, vessel wall


  Introduction
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Arterial calcification is commonly considered to be a deleterious process involving passive calcium accumulation in the intima during the complication of atherosclerotic plaques or in the media during aging or in diabetic people. Studies of the ultrastructural and biochemical composition of calcium deposits in atherosclerotic plaques have demonstrated that they are mainly in the form of hydroxyapatite, which is the type of calcium crystal found in bone (Schmid et al. 1980 ; Reid and Andersen 1993 ; Bobryshev et al. 1995 ). The ultrastructural feature of aortic wall mineralization during experimental atherogenesis has also been demonstrated in hypercholesterolemic swine (Daoud et al. 1985 ) and cholesterol-fed rabbits (Rokita et al. 1991 ). Identification of osteogenic differentiation factors in atherosclerotic lesions (Bostrom et al. 1993 ; Schluesener and Meyermann 1995 ) have led some authors to hypothesize that arterial calcification may be an active process (Bostrom et al. 1993 ; Doherty and Detrano 1994 ; Bini et al. 1999 ).

A large number of recent reports on the mechanisms of connective tissue mineralization and bone remodeling underline the potential role of three non-collagenous matrix proteins, osteopontin (OPN), osteonectin (ON), and osteocalcin (OC) (Holland et al. 1987 ; Price et al. 1987 ; Chen et al. 1993 ; Takano-Yamamoto et al. 1994 ).

OPN is an RGD-containing acidic phosphoprotein first isolated in bone (Oldberg et al. 1986 ). It is overexpressed by arterial smooth muscle cells (SMCs) according to their phenotype (Giachelli et al. 1991 ; Shanahan et al. 1993 ) and their position in the cell cycle (Gadeau et al. 1991 ). In vitro, OPN demonstrates adhesive and chemotactic activities for SMCs (Liaw et al. 1994 ) and its overexpression is closely associated with proliferation of this cell type (Gadeau et al. 1993 ; Ashizawa et al. 1996 ). In vascular tissue, OPN is strongly detected in the intima during neointimal formation induced by balloon injury (Giachelli et al. 1993 ) in association with areas of intense proliferation (Gadeau et al. 1994 ). OPN has also been characterized in human atherosclerotic plaques, in which it was synthesized by macrophages, SMCs, and endothelial cells (O'Brien et al. 1994 ), and it has been found to accumulate in calcified areas (Giachelli et al. 1993 ; Hirota et al. 1993 ; Fitzpatrick et al. 1994 ; Shanahan et al. 1994 ). OPN contains a hydroxyapatite binding site and a potential EF-hand calcium binding site, suggesting that this protein plays a role in calcium metabolism and potentially in the calcification process. Hunter et al. 1996 demonstrated that OPN is a potent inhibitor of hydroxyapatite formation, suggesting that OPN could have an inhibitory action on the calcification process. However, such a role has not been clearly demonstrated in the vessel wall.

OC is a vitamin K-dependent matrix protein that contains {gamma}-carboxyglutamic acid. In vitro, this protein strongly inhibits calcium salt precipitation (van de Loo et al. 1987 ), shows a strong affinity for hydroxyapatite, but inhibits crystal growth by delaying nucleation (Hunter et al. 1996 ). Although its role is still unclear, it has been demonstrated that OC normally limits bone formation (Ducy et al. 1996 ). In humans, OC has been demonstrated in calcified atherosclerotic plaques and calcified aortic valves (Levy et al. 1983 ).

ON, also called SPARC or BM40, is a secreted calcium binding protein involved in bone development (Mundlos et al. 1992 ) that demonstrates affinity for hydroxyapatite and collagen (Fujisawa et al. 1996 ; Sasaki et al. 1997 ). ON is detected in cultured SMCs (Severson et al. 1995 ) and is strongly expressed in young but not in healthy adult vessel walls. However, a few ON-expressing cells were scattered throughout the atherosclerosic lesions in humans (Hirota et al. 1993 ). Moreover, ON was found in association with large calcifications in human atherosclerotic plaques (Bini et al. 1999 ). ON also demonstrates a counter-adhesive effect on vitronectin-induced adhesion (Rosenblatt et al. 1997 ) and is involved in lowering the adhesiveness of tumor cells, thus increasing their invasive properties (Ledda et al. 1997 ). ON is also able to inhibit proliferation of endothelial cells and fibroblasts (Funk and Sage 1991 ; Pichler et al. 1996 ). We studied the distribution of OPN, ON, and OC during the early development of calcification in the rabbit model of injured aorta. Our results show that none of these proteins is detected in early calcifications but that OPN and OC are present in late calcium deposits, suggesting that these proteins might be involved in the control of calcification rather than in its genesis.


  Materials and Methods
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Tissue Collection and Staining Method
Animal studies were performed in accordance with French ministry of agriculture guidelines. Aortic tissues were obtained from male Fauve de Bourgogne rabbits. Animals were divided into two groups. In the first group, 6 month-old rabbits (n = 7) were fed for 6 months with an 0.3% cholesterol-enriched diet and sacrificed. In the second group, 3 month-old rabbits (n = 15) were subjected to aortic balloon injury (1.2–1.5 atm, three times) with a 3F angioplasty balloon (Baxter; Irvine, CA) after anesthesia by IM administration of 20 mg/kg ketamine (Imalgene) (Merial; Lyon, France) and 2 mg/kg xylazin (Rompum) (Bayer Pharma; Puteaux, France). Three rabbits were sacrificed after a defined duration of recovery (2, 4, 8, 14, or 30 days). Aortas were quickly dissected from the descending aorta to the iliac branch and eight pieces (0.5 cm) were removed at the same level in each aorta. As a control, a piece of healthy aorta was removed in all rabbits, just under the aortic arch, and was checked for calcification. These controls were always free of calcified deposits. Moreover, a healthy rabbit aorta was harvested under the same conditions and used as control. Aortas were fixed in ice-cold 4% paraformaldehyde for at least 3 hr. Specimens were rinsed in PBS, then embedded in paraffin. Seven-µm-thick sections were spread over APES (3-aminopropyltriethoxy-silane; Sigma-Aldrich, Saint–Quentin Fallavier, France)-coated slides.

Von Kossa-stained sections counterstained with Kernechtrot (Nuclear Fast Red) and Masson's trichrome were made according to classical methods (Gabe 1968 ). Quantitation of medial and calcified areas was performed on aortic cross-sections using a color video image analysis system (Quant'Image; INSERM U441, Bordeaux, France).

Calcium deposits were also specifically stained with Alizarin Red S and the sections were examined with a confocal microscope (Nikon PCM 2000) as previously described (Bernacca et al. 1994 ).

Immunohistochemistry
Serial sections were used for immunocytochemistry. SMCs were detected using an SM {alpha}-actin monoclonal antibody from Sigma-Aldrich, macrophages using RAM 11 monoclonal antibody from Dako (Trappes, France), OPN using MPIIIB10, and ON using AON-1 monoclonal antibodies purchased from DHSB, (Iowa City, IA) and OC using OCG2 from Takara (Biowhittaker Europe; Verviers, Belgium). Bound primary antibodies were detected using biotinylated anti-mouse secondary antibodies and the streptavidin–biotinylated horseradish peroxidase complex (Amersham Pharmacia Biotech; Orsay, France). The final complex was visualized by treatment with PBS containing 0.5 mg/ml diaminobenzidine and 0.03% H2O2 (Sigma-Aldrich). Antibody dilution and washes were carried out in PBS buffer containing 0.2% Tween-20 (Sigma-Aldrich) and 0.5% bovine serum albumin (ICN Biomedicals; Orsay, France). Controls were performed without primary antibodies and with nonspecific IgG1 antibody. To verify that antibodies did not bind nonspecifically to the calcium deposits, control sections with large calcifications were decalcified by 3% citric acid (Prolabo; Bordeaux, France) treatment for 1 hr before immunolabeling (Kockx et al. 1996 ).


  Results
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

OPN, OC, and ON Accumulation in Rabbit Atherosclerotic Plaques
Aortic calcification of cholesterol-enriched diet-fed rabbit occurred frequently (Rokita et al. 1991 ). These calcifications were found in atherosclerotic plaques or in the center part of the media (Fig 1A). OC and OPN, but not ON, were immunodetected in these calcified deposits (Fig 1B and Fig 1C).



View larger version (98K):
[in this window]
[in a new window]
 
Figure 1. Osteopontin and osteocalcin detection in rabbit medial calcinosis. Calcium deposits of cholesterol-fed rabbit aorta detected by von Kossa staining in the middle of the media (A) disappeared after citric acid treatment (D). Osteocalcin (B,E) and osteopontin (C,F) were detected in medial calcified areas either before (B,C) or after citric acid treatment (E,F) of sections. lu, lumen; adv, adventitia; black arrowheads show internal elastic laminae; empty arrowheads show external elastic laminae. Bar = 50 µm.

Figure 2. Morphology and kinetics of calcification of rabbit aorta after oversized balloon injury. Rabbit aortas were harvested before injury (A,E) or 2 days (B,F), 4 days (C,G,I), or 14 days (D,H) after 3F balloon injury. Serial sections were stained by either Masson's trichrome (A–D), von Kossa's staining (E–H), or Alizarin Red S (I). Calcified deposits stained by Alizarin Red S appear in red and elastic laminae in green using confocal microscopy. A yellow color indicating close association or overlapping between elastic laminae and calcification was not present. lu, lumen; adv, adventitia; black arrowheads show internal elastic laminae; empty arrowheads show external elastic laminae. Bars: AH = 50 µm; I = 10 µm.

Because hydroxyapatite has a high binding capacity for many proteins, we verified whether OPN and OC immunodetection found in calcified deposits was really due to the presence of OPN and OC antigens. Calcium phosphate was removed by a 1-hr citric acid treatment. Completion of calcium removal was controlled by the absence of black stain deposit after von Kossa staining (Fig 1D). However, a residual material, detected by Kernechtrot counterstaining (a nuclear red and cytoplasmic pink stain) remained in place of the calcium deposit. After this treatment, OC and OPN were still detected in the same areas with a nearly equal staining intensity to that in untreated sections (Fig 1E vs 1B and 1F vs 1C), demonstrating that the antibodies were not nonspecifically adsorbed on hydroxyapatite.

When primary antibody was omitted or replaced by nonspecific IgG1, the second antibody or streptavidin–peroxidase complex did not bind to calcifications (not shown).

Early Events in the Mineral Deposits
Early events in the mineral deposits were monitored in the rabbit aorta balloon injury model. The aortic injury was performed at 1.2–1.5 atm by moving a 3F angioplasty balloon from the thoracic to the abdominal aorta. Aortas were harvested either before injury or 2, 4, 8, 14, or 30 days after injury, and serial sections were made. Immunostaining with SM {alpha}-actin and RAM 11 antibodies demonstrated that only SMCs were detected in the injured tissue. At Day 30, some macrophages were observed in association with the calcification (not shown).

Masson's trichrome staining showed extensive structural tissue reorganization of the media in comparison to healthy aorta (Fig 2A). Two days and 4 days after injury, the interlaminae spaces mainly located in the inner half of the media were devoid of cells, as demonstrated by the absence of red cell staining (Fig 2B and Fig 2C). Sections of 8, 14, and 30 days were torn, suggesting the presence of "hard" components, such as calcified materials, in the media (Fig 2D shows a 14-day picture). Indeed, von Kossa's staining of serial sections showed that the arterial wound induced medial calcification. Although calcifications were never observed in healthy tissue (Fig 2E), 2 days after injury calcium deposits were found in the aorta of two of the three rabbits (Fig 2F). These deposits were not homogeneously distributed in the media but appeared only in cell-free areas. High magnification showed that calcified deposits were first present between the elastic laminae, mainly in association with remaining cellular materials stained by Kernechtrot (not shown). Confocal microscopic examination after Alizarin Red S treatment confirmed that the first calcified deposits (red fluorescence) were not closely associated with the elastic laminae (green autofluorescence) (Fig 2I). On Day 4, more extended calcifications were also detected in the media of two rabbits (Fig 2G), and deposits began to fill the empty areas in place of the cells between the elastic laminae. From Day 8, the elastic laminae were totally embedded in the calcified structure (not shown) and became fragmented into small pieces, and large calcium deposits demonstrating a dense, zipper-like morphology were present on Day 14 (Fig 2H). Therefore, calcium deposits rapidly increased between Days 2 and 4 after injury from 2.5–20% of the total media surface, reaching more than 30% 1 month later (Fig 3).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 3. Quantitative analysis of calcium deposit areas in rabbit aorta media after balloon injury. The ratio of calcium deposit areas to total medial area at the level of the calcified zones of the vessel was determined at different days after balloon injury. Four sections of calcified rabbit aortas (two for Days 2 and 4 and three for Days 8 and 30) were stained by the von Kossa stain and calcium deposit and total medial areas were evaluated using video color image analysis. Analysis of variance demonstrated differences between values on Days 2, 4, 8, 14, and 30 (ANOVA p<4 x 10-13). Ratios between Days 2 and 4 and between Days 4 and 8 were significantly increased (*) as determined by the Student's t-test (p<0.005).

Successive sections of injured aortas were investigated for OPN, OC, and ON protein location. OPN was not detected in healthy media (Fig 4A) but it appeared very rapidly 2 days after injury (Fig 4B). OPN was detected only in the remaining cells of injured media. In the same way, 4 days after injury, OPN was essentially detected in SMCs of the middle and internal part of the media (Fig 4C). At that time, OPN accumulation was not associated with very early calcified deposits. Then, from Day 8, OPN was detected in the neointima and also in the media, where it was clearly associated with calcified areas (Fig 4D).



View larger version (93K):
[in this window]
[in a new window]
 
Figure 4. Osteopontin accumulation in rabbit aortas after balloon injury. Rabbit aortas were harvested before injury (A) or 2 days (B), 4 days (C), or 14 days (D) after injury. Osteopontin was immunodetected (brown stain) in serial sections of specimens used in Fig 3. lu, lumen; adv, adventitia; black arrowheads show internal elastic laminae; empty arrowheads show external elastic laminae. Bar = 50 µm.

Figure 5. Osteocalcin accumulation in rabbit aortas after balloon injury. Rabbit aortas were harvested before injury (A) or 2 days (B), 4 days (C), or 14 days (D) after injury. Osteocalcin was immunodetected (brown coloration) in serial sections of specimens used in Fig 3. lu, lumen; adv, adventitia; black arrowheads show internal elastic laminae; empty arrowheads show external elastic laminae. Bar = 50 µm.

Figure 6. Detection of osteonectin in rabbit aortas after balloon injury. Rabbit aortas were harvested before injury (A) or 14 days (B) after balloon injury. Osteonectin was immunodetected (brown coloration) in serial sections of specimens used in Fig 3. lu, lumen; adv, adventitia; ca, calcium deposits; black arrowheads show internal elastic laminae; empty arrowheads show external elastic laminae. Bar = 50 µm.

In healthy rabbit and before the eighth day after injury, OC was not detected in the media (Fig 5A–5C). Then, from Day 14 after injury, OC accumulated in association with calcium deposits (Fig 5D) and began to be detected in SMCs. In healthy tissue, ON was detected only in endothelial cells and adventitia (Fig 6A), but 14 days after injury this protein was found in the intima, in the cellular part of the media, and all around but not inside calcifications (Fig 6B).


  Discussion
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

To understand the role of OPN, OC, and ON accumulation in calcified areas and their involvement in the initiation of this process, we developed a model of rapid aortic calcification that enabled us to follow non-collagenous bone proteins throughout the development of aortic calcification. In this model, severe aortic injury was induced by balloon angioplasty.

Surprisingly, calcified deposits appeared very rapidly, only 2–4 days after injury, in areas of the injured aortic media where cells had been killed. This rapid phenomenon, detected only in dead-cell areas, suggests that the early initiation of calcification is linked to SMC death, unveiling necrotic areas which can function as nidus for this process. During balloon injury a large number of cells were killed by crushing and by apoptosis (Perlman et al. 1997 ). However, 2 days after injury, this apoptosis phenomenon was quite completed and only very few TUNEL-positive cells could be detected (personal data). During initiation, calcified deposits were first observed in place of cells between elastic laminae but not in close association with them (demonstrated by confocal microscopy) as previously described by Bobryshev et al. 1995 , who hypothesized a role for damaged extracellular matrix elastin or collagen in calcium deposition. However, later on when the calcium crystals increased, many contacts with the elastic laminae were observed, as shown by these authors.

Our results suggest that the early steps of the calcification process after rabbit injury could be related to cell death. In this case, dead cells might create an active nucleation of calcium crystals. The mechanisms involved in the subsequent steps are not clearly understood but could involve the bone-associated matrix proteins detected in calcified deposits, OPN, OC, matrix Gla protein (MGP) (Shanahan et al. 1994 ), or bone sialoprotein (BSP) (personal observations). Indeed, recent studies suggest that OPN and OC may play a regulatory role in the bone calcification process (Chen et al. 1993 ; Denhardt and Guo 1993 ). However, the role of these proteins in arterial calcification is still unclear. In vitro physicochemical studies using a cell-free model have shown that OC and OPN have no ability to induce hydroxyapatite crystal formation (Hunter et al. 1996 ). Our results, showing that OPN and OC proteins were not present in very early calcification stages but appeared after calcified deposits were formed, suggest that these proteins are not necessary for initiation of arterial calcification. These findings are paralleled by in vitro studies showing the absence of OPN during the formation of calcified foci by pericytes in culture (Proudfoot et al. 1998 ). Our results also demonstrated that calcification appeared in cell-free areas in which OPN synthesis cannot occur.

Two weeks after injury, all calcified deposits contained OPN and OC, suggesting that these proteins were adsorbed on the calcium crystals because of their strong affinity for hydroxyapatite. This observation indicates that these proteins could be involved in the regulation of calcium crystal development. Although Ducy et al. 1996 demonstrated that OC limits bone formation without impairing mineralization, it has been shown in vitro that OC can delay hydroxyapatite nucleation and that OPN is a potent inhibitor of crystal growth (Shiraga et al. 1992 ; Hunter et al. 1996 ). Therefore, the hypothesis that these proteins are involved in the limitation of arterial wall calcification should be seriously considered. This is particularly so for OPN, which inhibits calcification of vascular SMC cultures (Wada et al. 1999 ). Although OPN and OC were detected in atherosclerotic plaques, it is not clear why pronounced hydroxyapatite formation was not inhibited in some advanced atherosclerotic plaques. It may be that the presence of a positive regulator of bone formation (Bostrom et al. 1993 ) and crystal growth, such as BSP, which exhibits hydroxyapatite nucleation activity (Hunter et al. 1996 ) and can bind collagenous matrix (Nagata et al. 1991 ), counterbalances the inhibition.

OPN and OC could come from the surrounding cells or from plasma that has infiltrated the injured aortic media. In the calcification of human atherosclerotic plaques, it has been shown that OPN may be of macrophage or SMC origin (O'Brien et al. 1994 ). In the media of rabbit balloon-injured aortas, during initiation of calcification only SMCs but not macrophages were detected. OPN at an early stage and OC later on were detected in medial and intimal SMCs and also in adventitial cells when calcium deposits accumulated, demonstrating the role of these cells in the production of OPN and OC associated with calcified structures. Moreover, OPN and OC can come from plasma because it has been reported that these proteins are present in serum (Jie et al. 1995 ; Panda et al. 1997 ).


  Acknowledgments

Supported by grants from Institut National de la Santé et de la Recherche Médicale.

We wish to thank P. Alzieu for excellent technical assistance. Monoclonal antibodies MPIIIB 10 (1) developed by M. Solursh/A. Franzen and AON-1 developed by J.D. Termine were obtained from the Developmental Studies Hybridoma Bank under the auspices of NICHD and maintained by the University of Iowa Department of Biological Sciences (Iowa City, IA).

Received for publication March 28, 2000; accepted August 23, 2000.


  Literature Cited
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Ashizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, Meehan WP, Tuan TL, Hsueh WA (1996) Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. J Clin Invest 98:2218-2227[Abstract/Free Full Text]

Bernacca GM, Gibson SA, Wilkinson R, Wheatley DJ (1994) Confocal laser scanning microscopy of calcified bioprosthetic heart valves. J Heart Valve Dis 3:205-211[Medline]

Bini A, Mann KG, Kudryk BJ, Schoen FJ (1999) Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 19:1852-1861[Abstract/Free Full Text]

Bobryshev YV, Lord RS, Warren BA (1995) Calcified deposit formation in intimal thickenings of the human aorta. Atherosclerosis 118:9-21[Medline]

Boström K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL (1993) Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91:1800-1809[Medline]

Chen J, Singh K, Mukherjee BB, Sodek J (1993) Developmental expression of osteopontin (OPN) mRNA in rat tissues: evidence for a role for OPN in bone formation and resorption. Matrix 13:113-123[Medline]

Daoud AS, Frank AS, Jarmolych J, Franco WT, Fritz KE (1985) Ultrastructural and elemental analysis of calcification of advanced swine aortic atherosclerosis. Exp Mol Pathol 43:337-347[Medline]

Denhardt DT, Guo X (1993) Osteopontin: a protein with diverse functions. FASEB J 7:1475-1482[Abstract/Free Full Text]

Doherty TM, Detrano RC (1994) Coronary arterial calcification as an active process: a new perspective on an old problem. Calcif Tissue Int 54:224-230[Medline]

Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G (1996) Increased bone formation in osteocalcin-deficient mice. Nature 382:448-452[Medline]

Fitzpatrick LA, Severson A, Edwards WD, Ingram RT (1994) Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest 94:1597-1604[Medline]

Fujisawa R, Wada Y, Nodasaka Y, Kuboki Y (1996) Acidic amino acid-rich sequences as binding sites of osteonectin to hydroxyapatite crystals. Biochim Biophys Acta 1292:53-60[Medline]

Funk SE, Sage EH (1991) The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc Natl Acad Sci USA 88:2648-2652[Abstract]

Gabe M (1968) Techniques Histologiques. Paris, Masson

Gadeau AP, Campan M, Desgranges C (1991) Induction of cell cycle-dependent genes during cell cycle progression of arterial smooth muscle cells in culture. J Cell Physiol 146:356-361[Medline]

Gadeau AP, Campan M, Millet D, Candresse T, Desgranges C (1993) Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arterioscler Thromb 13:120-125[Abstract]

Gadeau A-P, Capron L, Dupuch F, Poulette S, Desgranges C (1994) Osteopontin overexpression during in vitro and in vivo proliferative process of arterial smooth muscle cells. J Mol Cell Cardiol 26:XX

Giachelli C, Bae N, Lombardi D, Majesky M, Schwartz S (1991) Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). Biochem Biophys Res Commun 177:867-873[Medline]

Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM (1993) Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 92:1686-1696[Medline]

Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim HM, Kitamura Y, Yutani C, Nomura S (1993) Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification. Am J Pathol 143:1003-1008[Abstract]

Holland PW, Harper SJ, McVey JH, Hogan BL (1987) In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridization. J Cell Biol 105:473-482[Abstract]

Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA (1996) Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 317(pt 1):59-64[Medline]

Jie KS, Bots ML, Vermeer C, Witteman JC, Grobbee DE (1995) Vitamin K intake and osteocalcin levels in women with and without aortic atherosclerosis: a population-based study. Atherosclerosis 116:117-123[Medline]

Kockx MM, Muhring J, Bortier H, De Meyer GR, Jacob W (1996) Biotin- or digoxigenin-conjugated nucleotides bind to matrix vesicles in atherosclerotic plaques. Am J Pathol 148:1771-1777[Abstract]

Ledda MF, Adris S, Bravo AI, Kairiyama C, Bover L, Chernajovsky Y, Mordoh J, Podhajcer OL (1997) Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nature Med 3:171-176[Medline]

Levy RJ, Gundberg C, Scheinman R (1983) The identification of the vitamin K-dependent bone protein osteocalcin as one of the gamma-carboxyglutamic acid containing proteins present in calcified atherosclerotic plaque and mineralized heart valves. Atherosclerosis 46:49-56[Medline]

Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM (1994) Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 74:214-224[Abstract]

Mundlos S, Schwahn B, Reichert T, Zabel B (1992) Distribution of osteonectin mRNA and protein during human embryonic and fetal development. J Histochem Cytochem 40:283-291[Abstract/Free Full Text]

Nagata T, Bellows CG, Kasugai S, Butler WT, Sodek J (1991) Biosynthesis of bone proteins [SPP-1 (secreted phosphoprotein-1, osteopontin), BSP (bone sialoprotein) and SPARC (osteonectin)] in association with mineralized-tissue formation by fetal-rat calvarial cells in culture. Biochem J 274(pt 2):513-520[Medline]

O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM (1994) Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb 14:1648-1656[Abstract]

Oldberg A, Franzén A, Heinegård D (1986) Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 83:8819-8823[Abstract]

Panda D, Kundu GC, Lee BI, Peri A, Fohl D, Chackalaparampil I, Mukherjee BB, Li XD, Mukherjee DC, Seides S, Rosenberg J, Stark K, Mukherjee AB (1997) Potential roles of osteopontin and alphaVbeta3 integrin in the development of coronary artery restenosis after angioplasty. Proc Natl Acad Sci USA 94:9308-9313[Abstract/Free Full Text]

Perlman H, Maillard L, Krasinski K, Walsh K (1997) Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation 95:981-987[Abstract/Free Full Text]

Pichler RH, Bassuk JA, Hugo C, Reed MJ, Eng E, Gordon KL, Pippin J, Alpers CE, Couser WG, Sage EH, Johnson RJ (1996) SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-mediated mesangial cell proliferation in vitro. Am J Pathol 148:1153-1167[Abstract]

Price PA, Fraser JD, Metz–Virca G (1987) Molecular cloning of matrix Gla protein: implications for substrate recognition by the vitamin K-dependent gamma-carboxylase. Proc Natl Acad Sci USA 84:8335-8339[Abstract]

Proudfoot D, Skepper JN, Shanahan CM, Weissberg PL (1998) Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. Arterioscler Thromb Vasc Biol 18:379-388[Abstract/Free Full Text]

Reid JD, Andersen ME (1993) Medial calcification (whitlockite) in the aorta. Atherosclerosis 101:213-224[Medline]

Rokita E, Cichocki T, Heck D, Jarczyk L, Strzalkowski A (1991) Calcification of aortic wall in cholesterol-fed rabbits. Atherosclerosis 87:183-193[Medline]

Rosenblatt S, Bassuk JA, Alpers CE, Sage EH, Timpl R, Preissner KT (1997) Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: characterization of the binding of vitronectin to osteonectin (BM40, SPARC). Biochem J 324(pt 1):311-319[Medline]

Sasaki T, Gohring W, Mann K, Maurer P, Hohenester E, Knäuper V, Murphy G, Timpl R (1997) Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J Biol Chem 272:9237-9243[Abstract/Free Full Text]

Schluesener HJ, Meyermann R (1995) Immunolocalization of BMP-6, a novel TGF-beta-related cytokine, in normal and atherosclerotic smooth muscle cells. Atherosclerosis 113:153-156[Medline]

Schmid K, McSharry WO, Pameijer CH, Binette JP (1980) Chemical and physicochemical studies on the mineral deposits of the human atherosclerotic aorta. Atherosclerosis 37:199-210[Medline]

Severson AR, Ingram RT, Fitzpatrick LA (1995) Matrix proteins associated with bone calcification are present in human vascular smooth muscle cells grown in vitro. In Vitro Cell Dev Biol Anim 31:853-857[Medline]

Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL (1994) High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 93:2393-2402[Medline]

Shanahan CM, Weissberg PL, Metcalfe JC (1993) Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res 73:193-204[Abstract]

Shiraga H, Min W, VanDusen WJ, Clayman MD, Miner D, Terrell CH, Sherbotie JR, Foreman JW, Przysiecki C, Neilson EG, Hoyer JR (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89:426-430[Abstract]

Takano–Yamamoto T, Takemura T, Kitamura Y, Nomura S (1994) Site-specific expression of mRNAs for osteonectin, osteocalcin, and osteopontin revealed by in situ hybridization in rat periodontal ligament during physiological tooth movement. J Histochem Cytochem 42:885-896[Abstract/Free Full Text]

van de Loo PG, Soute BA, van Haarlem LJ, Vermeer C (1987) The effect of Gla-containing proteins on the precipitation of insoluble salts. Biochem Biophys Res Commun 142:113-119[Medline]

Wada T, McKee MD, Steitz S, Giachelli CM (1999) Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res 84:166-178[Abstract/Free Full Text]